Childhood Stress Linked to Higher Risk of Heart Disease in Adulthood

Translate to Spanish or other 102 languages!

Researchers stress during childhood can lead to health issues in adulthood. Image for illustration purposes
Researchers stress during childhood can lead to health issues in adulthood. Image for illustration purposes
- Advertisement -
  • Researchers are reporting that stress early in life can contribute to cardiometabolic diseases in adulthood.
  • They say that’s because high levels of stress hormones may contribute to heart disease.
  • Experts say there are a number of ways parents can help children understand and deal with stress.

Stress in adolescence and early adulthood may contribute to the development of cardiometabolic diseases later in life, according to a studyTrusted Source published today in the Journal of the American Heart Association.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/childhood-stress-linked-to-higher-risk-of-heart-disease-in-adulthood?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-01-18&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Skin Myths Dermatologists Want You to Stop Believing Immediately

Have you ever wondered what a dermatologist's top skincare recommendations are

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.
- Advertisement -